Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Generic drugmaker Mylan announced layoffs of about 15 percent of its workforce at their manufacturing plant in Morgantown, West Virginia.
read more
Friday, November 04, 2022
Medmix Drug Delivery (Haselmeier) and AARDEX Group announced a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.
read more
AGC Biologics and BioConnection have announced a new strategic partnership. The companies are partnering to provide end- to-end biopharmaceutical development and manufacturing capabilities for drug substance and drug product using the development and...
read more
Tuesday, January 29, 2019
Pivot announced the company has entered into a contract manufacturing agreement with Growpacker to produce Pivot's topical gels, creams and beverages for the California cannabis market.
read more
Thursday, October 03, 2013
Cytovance Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces that they have entered into a manufacturing agreement with Translational Sciences, Inc., a Memphis, Tennessee-based clinical ...
read more
Wednesday, February 17, 2016
Asterand Bioscience has been awarded a five-year, $6.5M contract from the National Institutes of Health (NIH) to provide oncology specimens with associated clinical data to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).
read more
Piramal Pharma Solutions (PPS) announced that its Grangemouth, UK facility has completed production of its 1,500th antibody-drug conjugate (ADC) batch. The milestone batch represents a commercial oncology product.
read more
Teknova has expanded the production capacity for its range of viral transport media. This strategy enables the company to continue supplying products in periods of high demand.
read more
Tuesday, January 17, 2023
CN Bio announced that the FDA and CN Bio have expanded their collaboration for the second time, with new research aiming to evaluate multi-organ MPS and their applications using the PhysioMimix™ Multi-organ System.
read more
Thursday, August 07, 2025
Arcinova, a Quotient Sciences company, and UK-based Contract Research Development and Manufacturing Organization (CRDMO), announced the appointment of Dr. Christian Dowdeswell as new Managing Director.
read more
Tuesday, February 10, 2026
AsymBio, a subsidiary of Asymchem Group , announced that it has established integrated technology platforms spanning the full biopharmaceutical development lifecycle. Through its end-to-end service capabilities, the company provides streamlined, ...
read more
Thursday, November 02, 2017
The companies’ collaboration will support the adoption of MC10’s proprietary technology for use by LabCorp’s Covance Drug Development business in clinical trials and research studies.
read more
Wednesday, August 12, 2020
Caprion-HistoGeneX and Viroclinics-DDL have announced a partnership that will offer global, integrated services to support discovery and development of vaccines and antiviral therapies.
read more
Tuesday, January 28, 2014
Ajinomoto Althea, Inc., a leading Contract Manufacturing Organization providing development and manufacturing services for biotechnology and pharmaceutical companies, announced today its new product offering, Corynex®, to produce secreted, soluble, ...
read more
Wednesday, April 10, 2024
Charles River Laboratories International, Inc. announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with Axovia Therapeutics Ltd. Charles River will manufacture High Quality (HQ) gene of interest plasmid to...
read more